Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Income from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)
Others
Ratios

Jupiter Neurosciences (JUNS) Shares Outstanding (Diluted Average) (2024 - 2025)

Jupiter Neurosciences (JUNS) has disclosed Shares Outstanding (Diluted Average) for 2 consecutive years, with $34.6 million as the latest value for Q4 2025.

  • Quarterly Shares Outstanding (Diluted Average) rose 20.31% to $34.6 million in Q4 2025 from the year-ago period, while the trailing twelve-month figure was $34.6 million through Dec 2025, up 20.31% year-over-year, with the annual reading at $34.6 million for FY2025, 20.31% up from the prior year.
  • Shares Outstanding (Diluted Average) for Q4 2025 was $34.6 million at Jupiter Neurosciences, up from $33.4 million in the prior quarter.
  • The five-year high for Shares Outstanding (Diluted Average) was $34.6 million in Q4 2025, with the low at $26.5 million in Q1 2024.